Related Experiment Video
Updated: Aug 15, 2026

16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Benefits and risks of immunization against pertussis
Summary
Pertussis vaccine (DTP) significantly controls whooping cough. Declining DTP vaccination rates led to a major epidemic, highlighting the importance of immunization despite concerns about vaccine side effects.
Area of Science:
- Immunology
- Epidemiology
- Public Health
Background:
- The incidence of pertussis (whooping cough) in the UK over the past 30 years has been influenced by pertussis vaccine (DTP) acceptance rates.
- A significant pertussis epidemic began in November 1977, following a sharp decline in DTP vaccination coverage from 70-80% in 1973 to under 40% in 1976.
Purpose of the Study:
- To describe the benefit of pertussis vaccine in controlling pertussis.
- To examine the relationship between DTP vaccine acceptance and pertussis incidence.
- To address public concerns regarding vaccine hazards and promote immunization.
Main Methods:
- Analysis of pertussis incidence trends in the UK over 30 years.
- Review of reported vaccine reactions, including minor, systemic, and neurological events.
- Description of prospective studies on post-vaccination reactions and a national study on encephalopathy.
Main Results:
- A decline in DTP vaccination acceptance preceded a major pertussis epidemic.
- While vaccine hazards exist (local, febrile reactions), serious neurological illnesses are not definitively linked to DTP and do not appear more frequent than in unvaccinated children.
- Ongoing studies are investigating potential links between DTP and encephalopathy.
Conclusions:
- Pertussis vaccine (DTP) plays a crucial role in controlling pertussis outbreaks.
- Public perception of vaccine risks, often amplified by publicity, hinders acceptance.
- Improved health education is necessary to underscore the benefits of DTP immunization.
Related Concept Videos
Vaccinations
Overview
Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

